Clinical Trial Update: Hybrid-APC Margin Ablation to Prevent Post EMR Adenoma Recurrence [NA]

View source ↗

Summary

This clinical trial update reports results for Hybrid-APC Margin Ablation aimed at preventing recurrence of colon adenomas after endoscopic mucosal resection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Polyp
• Colorectal Cancer

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Colorectal Cancer, Polyp of Colon | NA | Status: COMPLETED